17
Participants
Start Date
January 10, 2019
Primary Completion Date
March 15, 2020
Study Completion Date
March 15, 2020
Medical Cannabis
The experimental intervention will begin with two weeks of titration (100 mg to 200 mg of CBD per day), followed by four weeks of treatment (maximum 300 mg of CBD per day) and four weeks of maintenance (maximum 300 mg of CBD per day). A two week washout phase will slowly decrease the daily dose (200 mg to 100 mg of CBD per day). All daily doses are equally divided into a morning and evening dose.
Placebo
The placebo intervention will begin with two weeks of titration, followed by four weeks of treatment. Participants will then be unblinded to their study group and begin two weeks of titration, four weeks of treatment, and two weeks of washout with medical cannabis, following the same dosing and schedule as the experimental group. All daily doses are equally divided into a morning and evening dose.
University Hospital Campus, London Health Sciences Centre, London
University Health Network - Toronto Western Hospital, Toronto
Collaborators (3)
Ontario Brain Institute
OTHER
University of Toronto
OTHER
University Health Network, Toronto
OTHER
London Health Sciences Centre
OTHER
MedReleaf
INDUSTRY
The Epilepsy Research Program of the Ontario Brain Institute
OTHER